{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T05:38:10Z","timestamp":1732772290359,"version":"3.29.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,27]]},"DOI":"10.7759\/cureus.74618","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T02:47:11Z","timestamp":1732762031000},"source":"Crossref","is-referenced-by-count":0,"title":["Late-Onset Idiopathic Generalized Epilepsy Manifesting With De Novo Late-Onset Absence Status Epilepticus After COVID-19 Infection: A Case Report"],"prefix":"10.7759","author":[{"given":"Mao","family":"Otake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.npbr.2020.10.001","article-title":"Seizure and COVID-19: association and review of potential mechanism","volume":"38","author":"Narula N","year":"2020","unstructured":"Narula N, Joseph R, Katyal N, Daouk A, Acharya S, Avula A, Maroun R. Seizure and COVID-19: association and review of potential mechanism. Neurol Psychiatry Brain Res. 2020, 38:49-53. 10.1016\/j.npbr.2020.10.001","journal-title":"Neurol Psychiatry Brain Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201595","article-title":"Incidence of epilepsy and seizures over the first 6 months after a COVID-19 diagnosis: a retrospective cohort study","volume":"100","author":"Taquet M","year":"2023","unstructured":"Taquet M, Devinsky O, Cross JH, Harrison PJ, Sen A. Incidence of epilepsy and seizures over the first 6 months after a COVID-19 diagnosis: a retrospective cohort study. Neurology. 2023, 100:e790-9. 10.1212\/WNL.0000000000201595","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2023.100584","article-title":"Possible post-COVID epilepsy: a review of epilepsy monitoring unit admissions during the two years of COVID-19 pandemic","volume":"21","author":"Dunn E","year":"2023","unstructured":"Dunn E, Ibrahim F, Neme-Mercante S, Nair D, Morris S, Wang I, Punia V. Possible post-COVID epilepsy: a review of epilepsy monitoring unit admissions during the two years of COVID-19 pandemic. Epilepsy Behav Rep. 2023, 21:84. 10.1016\/j.ebr.2023.100584","journal-title":"Epilepsy Behav Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106650","article-title":"Acute symptomatic seizures and COVID-19: hospital-based study","volume":"174","author":"Khedr EM","year":"2021","unstructured":"Khedr EM, Shoyb A, Mohammaden M, Saber M. Acute symptomatic seizures and COVID-19: hospital-based study. Epilepsy Res. 2021, 174:50. 10.1016\/j.eplepsyres.2021.106650","journal-title":"Epilepsy Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2018.0961","article-title":"De novo late-onset absence status epilepticus or late-onset idiopathic generalized epilepsy? A case report and systematic review of the literature","volume":"20","author":"Brigo F","year":"2018","unstructured":"Brigo F, Tavernelli V, Nardone R, Trinka E. De novo late-onset absence status epilepticus or late-onset idiopathic generalized epilepsy? A case report and systematic review of the literature. Epileptic Disord. 2018, 20:123-31. 10.1684\/epd.2018.0961","journal-title":"Epileptic Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22393","article-title":"EEG criteria for diagnosing nonconvulsive status epilepticus in comatose - an unsolved puzzle: a narrative review","volume":"9","author":"Zafar A","year":"2023","unstructured":"Zafar A, Aljaafari D. EEG criteria for diagnosing nonconvulsive status epilepticus in comatose - an unsolved puzzle: a narrative review. Heliyon. 2023, 9:e22393. 10.1016\/j.heliyon.2023.e22393","journal-title":"Heliyon"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208076","article-title":"Idiopathic generalized epilepsy: misunderstandings, challenges, and opportunities","volume":"102","author":"Devinsky O","year":"2024","unstructured":"Devinsky O, Elder C, Sivathamboo S, Scheffer IE, Koepp MJ. Idiopathic generalized epilepsy: misunderstandings, challenges, and opportunities. Neurology. 2024, 102:e208076. 10.1212\/WNL.0000000000208076","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb02421.x","article-title":"De novo absence status epilepticus as a benzodiazepine withdrawal syndrome","volume":"34","author":"Thomas P","year":"1993","unstructured":"Thomas P, Lebrun C, Chatel M. De novo absence status epilepticus as a benzodiazepine withdrawal syndrome. Epilepsia. 1993, 34:355-8. 10.1111\/j.1528-1157.1993.tb02421.x","journal-title":"Epilepsia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2008.08.005","article-title":"Typical absence status epilepticus as late presentation of idiopathic generalised epilepsy in an elderly patient","volume":"18","author":"Fern\u00e1ndez-Torre JL","year":"2009","unstructured":"Fern\u00e1ndez-Torre JL, Rebollo M. Typical absence status epilepticus as late presentation of idiopathic generalised epilepsy in an elderly patient. Seizure. 2009, 18:82-3. 10.1016\/j.seizure.2008.08.005","journal-title":"Seizure"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2104115","article-title":"SARS-CoV-2 infection and seizures: the perfect storm","volume":"21","author":"Tsai C","year":"2022","unstructured":"Tsai C, Wilson SE, Rubinos C. SARS-CoV-2 infection and seizures: the perfect storm. J Integr Neurosci. 2022, 21:115. 10.31083\/j.jin2104115","journal-title":"J Integr Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107335","article-title":"Seizure as the presenting symptom of COVID-19: a retrospective case series","volume":"112","author":"Anand P","year":"2020","unstructured":"Anand P, Al-Faraj A, Sader E, et al.. Seizure as the presenting symptom of COVID-19: a retrospective case series. Epilepsy Behav. 2020, 112:107335. 10.1016\/j.yebeh.2020.107335","journal-title":"Epilepsy Behav"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.107887","article-title":"Status epilepticus and COVID-19: a systematic review","volume":"118","author":"Dono F","year":"2021","unstructured":"Dono F, Nucera B, Lanzone J, et al.. Status epilepticus and COVID-19: a systematic review. Epilepsy Behav. 2021, 118:107887. 10.1016\/j.yebeh.2021.107887","journal-title":"Epilepsy Behav"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26060","article-title":"Electroencephalographic abnormalities are common in COVID-19 and are associated with outcomes","volume":"89","author":"Lin L","year":"2021","unstructured":"Lin L, Al-Faraj A, Ayub N, et al.. Electroencephalographic abnormalities are common in COVID-19 and are associated with outcomes. Ann Neurol. 2021, 89:872-83. 10.1002\/ana.26060","journal-title":"Ann Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.1489","article-title":"Association of clinical, biological, and brain magnetic resonance imaging findings with electroencephalographic findings for patients with COVID-19","volume":"4","author":"Lambrecq V","year":"2021","unstructured":"Lambrecq V, Hanin A, Munoz-Musat E, et al.. Association of clinical, biological, and brain magnetic resonance imaging findings with electroencephalographic findings for patients with COVID-19. JAMA Netw Open. 2021, 4:e211489. 10.1001\/jamanetworkopen.2021.1489","journal-title":"JAMA Netw Open"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.42.1.104","article-title":"'De novo' absence status of late onset: report of 11 cases","volume":"42","author":"Thomas P","year":"1992","unstructured":"Thomas P, Beaumanoir A, Genton P, Dolisi C, Chatel M. 'De novo' absence status of late onset: report of 11 cases. Neurology. 1992, 42:104-10. 10.1212\/wnl.42.1.104","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2011.03.009","article-title":"Idiopathic late-onset absence status epilepticus: a case report with an electroclinical 14 years follow-up","volume":"20","author":"Pro S","year":"2011","unstructured":"Pro S, Vicenzini E, Randi F, Pulitano P, Mecarelli O. Idiopathic late-onset absence status epilepticus: a case report with an electroclinical 14 years follow-up. Seizure. 2011, 20:655-8. 10.1016\/j.seizure.2011.03.009","journal-title":"Seizure"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.3400","article-title":"Levetiracetam vs lamotrigine as first-line antiseizure medication in female patients with idiopathic generalized epilepsy","volume":"80","author":"Cerulli Irelli E","year":"2023","unstructured":"Cerulli Irelli E, Cocchi E, Morano A, et al.. Levetiracetam vs lamotrigine as first-line antiseizure medication in female patients with idiopathic generalized epilepsy. JAMA Neurol. 2023, 80:1174-81. 10.1001\/jamaneurol.2023.3400","journal-title":"JAMA Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures","volume":"70","author":"Noachtar S","year":"2008","unstructured":"Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology. 2008, 70:607-16. 10.1212\/01.wnl.0000297512.18364.40","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2011.05.007","article-title":"Aggravation of absence seizure related to levetiracetam","volume":"15","author":"Auvin S","year":"2011","unstructured":"Auvin S, Chhun S, Berquin P, Ponchel E, Delano\u00eb C, Chiron C. Aggravation of absence seizure related to levetiracetam. Eur J Paediatr Neurol. 2011, 15:508-11. 10.1016\/j.ejpn.2011.05.007","journal-title":"Eur J Paediatr Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.40903.x","article-title":"Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study","volume":"45","author":"Coppola G","year":"2004","unstructured":"Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia. 2004, 45:1049-53. 10.1111\/j.0013-9580.2004.40903.x","journal-title":"Epilepsia"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal (lamotrigine) monotherapy for typical absence seizures in children","volume":"40","author":"Frank LM","year":"1999","unstructured":"Frank LM, Enlow T, Holmes GL, et al.. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia. 1999, 40:973-9. 10.1111\/j.1528-1157.1999.tb00805.x","journal-title":"Epilepsia"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02234.x","article-title":"Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy","volume":"50","author":"Penovich PE","year":"2009","unstructured":"Penovich PE, Willmore LJ. Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy. Epilepsia. 2009, 50:37-41. 10.1111\/j.1528-1167.2009.02234.x","journal-title":"Epilepsia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-023-01183-0","article-title":"Prognosis and management of acute symptomatic seizures: a prospective, multicenter, observational study","volume":"13","author":"Herzig-Nichtwei\u00df J","year":"2023","unstructured":"Herzig-Nichtwei\u00df J, Salih F, Berning S, et al.. Prognosis and management of acute symptomatic seizures: a prospective, multicenter, observational study. Ann Intensive Care. 2023, 13:85. 10.1186\/s13613-023-01183-0","journal-title":"Ann Intensive Care"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052681","article-title":"Interactions of SARS-CoV-2 with the blood-brain barrier","volume":"22","author":"Erickson MA","year":"2021","unstructured":"Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the blood-brain barrier. Int J Mol Sci. 2021, 22:10.3390\/ijms22052681","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-024-01576-9","article-title":"Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment","volume":"27","author":"Greene C","year":"2024","unstructured":"Greene C, Connolly R, Brennan D, et al.. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024, 27:421-32. 10.1038\/s41593-024-01576-9","journal-title":"Nat Neurosci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050816","article-title":"Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics","volume":"12","author":"Leng A","year":"2023","unstructured":"Leng A, Shah M, Ahmad SA, et al.. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells. 2023, 12:16. 10.3390\/cells12050816","journal-title":"Cells"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/0004563220922255","article-title":"Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19)","volume":"57","author":"Lippi G","year":"2020","unstructured":"Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020, 57:262-5. 10.1177\/0004563220922255","journal-title":"Ann Clin Biochem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.47.5.1203","article-title":"Visual working memory in primary generalized epilepsy: an 18FDG-PET study","volume":"47","author":"Swartz BE","year":"1996","unstructured":"Swartz BE, Simpkins F, Halgren E, Mandelkern M, Brown C, Krisdakumtorn T, Gee M. Visual working memory in primary generalized epilepsy: an 18FDG-PET study. Neurology. 1996, 47:1203-12. 10.1212\/wnl.47.5.1203","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317907-late-onset-idiopathic-generalized-epilepsy-manifesting-with-de-novo-late-onset-absence-status-epilepticus-after-covid-19-infection-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T02:47:12Z","timestamp":1732762032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317907-late-onset-idiopathic-generalized-epilepsy-manifesting-with-de-novo-late-onset-absence-status-epilepticus-after-covid-19-infection-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.74618","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}